| 标题 |
Efficacy, safety, and predictive biomarkers of dalpiciclib combined with letrozole, pertuzumab and trastuzumab as neoadjuvant therapy in HR+/HER2+ breast cancer: A phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Xinrui Liang; Jing Wu; Ningning Zhang; Xiaohua Zeng 出版日期:2024-08-05 |
| 求助人 | |
| 下载 |
pugongying
Lv3 求助人 发起了本次求助
PDF的下载单位、IP信息已删除
(2025-6-4)